Novartis has announced a new malaria treatment called GanLum. The drug contains a novel molecule named ganaplacide that works in a different way from current antimalarials, so the parasite has no prior defence.
A late-stage trial included over 1,600 patients in 12 countries in sub‑Saharan Africa. Given as a sachet of granules once a day for three days, GanLum cured 97.4% of participants, compared with 94% for an existing treatment. Medicines for Malaria Venture said regulatory approvals could come in about 16 months, and the drug could be available on the market in 2027.
Difficult words
- drug — A substance used to treat illness.medicines
- effective — Works well to achieve desired result.
- malaria — A serious disease spread by mosquitoes.
- treating — To give care or medicine for an illness.treatments
- trial — A test to check the effectiveness of something.trials
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why is it important to have new treatments for malaria?
- How do you think GanLum will change malaria treatment?
- What are the benefits of clinical trials for new drugs?
Related articles
Biodegradable patch may help heart heal after heart attack
Researchers report a biodegradable microneedle patch that delivers interleukin-4 to injured heart tissue. The local treatment encourages healing immune cells, reduces scarring, and may improve heart recovery while avoiding systemic side effects.
Disposable gloves can cause false microplastic counts
University of Michigan researchers found that coatings on disposable nitrile and latex gloves can leave stearate residues that look like microplastics. The contamination can affect filters and slides used for air, water and other samples.